Nuclotixene

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6DTQ2MGV34. European Medicines Agency schedules Nuclotixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09389MIG. Nuclotixene generally arises in the molecular formula C21H20CLNS. The term NUCLOTIXENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) NUCLOTIXENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nuclotixene under HS 29349990 and SITC 51579. As of Q4 2014, NUCLOTIXENE remains the US FDA Preferred Term for this commodity. Nuclotixene bears US NLM identifiers UMLS ID C2825653 and NCI Concept Code C81481. SMILES: Clc1cc2/C(=C/C3C4CCN(C3)CC4)c3c(Sc2cc1)cccc3.